<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00233688</url>
  </required_header>
  <id_info>
    <org_study_id>P01-4601</org_study_id>
    <nct_id>NCT00233688</nct_id>
  </id_info>
  <brief_title>Study of the Endovascular QUANTUM LP™ Stent Graft System in Abdominal Aortic Aneurysms (AAA)</brief_title>
  <official_title>A Prospective, Multicenter Study of the Cordis Endovascular QUANTUM LP™ Stent Graft System for the Treatment of Abdominal Aortic Aneurysms (AAA)-FORTRON</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cordis Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cordis Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this clinical study is to assess the safety and effectiveness of the Cordis
      Endovascular Quantum LP™ Stent Graft System.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2001</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">December 2004</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To compare the aneurysm-related one-year mortality rates of the stent graft patients to open surgery patients. The purpose of having an aneurysm surgically or endovascularly repaired is to prevent death from AAA.</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>To compare the one-year procedure-related severe adverse event rates of the stent graft patients to open surgery patients. These events exclude aneurysm-related deaths. The endpoint for this objective will be the occurrence of any serious adverse eve</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate the occurrence of severe device-related adverse events as they relate to the cause of aneurysm exclusion failures (i.e., Type I and III endoleaks, significant AAA growth, or AAA rupture).</measure>
    <time_frame>30 days, 6 mo, and annually up to five years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To compare the rate and amount of blood products used in the stent graft procedure to open surgery.</measure>
    <time_frame>At procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Abdominal Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>QUANTUM LP™ STENT GRAFT SYSTEM</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Surgical intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>QUANTUM LP™ STENT GRAFT SYSTEM</intervention_name>
    <description>Stent Graft System for the Treatment of Abdominal Aortic Aneurysms</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open surgical repair</intervention_name>
    <description>Open surgical repair</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria (Surgical Patients):

          1. Non-emergent surgical candidate (aneurysm has not ruptured)

          2. Patients 21 years of age or older

          3. Male or infertile Female

          4. Aneurysm &gt;/=4.5 cm in diameter, or

          5. Aneurysm &gt;/= twice the normal aortic diameter directly above the aneurysm, or

          6. Aneurysm &gt;/= 4.0 cm in diameter and rapidly growing (0.5 cm in 6 months), or

          7. Saccular aneurysm &gt; 3.0 cm

        Inclusion Criteria (Stent Graft Patients)

          1. Patient meets all inclusion criteria for surgical candidate

          2. Aneurysm starts &gt;/= 10 mm below the most distal main renal artery and the diameter of
             aorta within that aortic neck segment is not variable

          3. Diameter of aortic fixation zone (neck) &gt;/= 22mm and &lt;/= 30 mm

          4. Supra renal aortic diameter &lt;/= 34 mm

          5. The required device coverage length &gt;/= 13 cm extending from most distal main renal
             artery ostium to the distal anchoring site within the common iliac artery (or external
             iliac artery if planned occlusion of internal iliac artery)

          6. Aortic neck angulation &lt; 60° as estimated from CT scan images or angiogram

          7. Iliac artery attachment zone diameter &lt;/= 20 mm

          8. Iliac arteries with a length of &gt;/= 10 mm of non-aneurysmal vessel located at the
             iliac graft attachment sites

          9. Iliac arteries with adequate peripheral access to accommodate a 22 Fr catheter
             delivery system

         10. Aortic bifurcation &gt; 18 mm in diameter

         11. Creatinine level &lt; 2.5 mg/dl

        Exclusion Criteria (Surgical and Stent Graft Patients):

          1. Weight &gt; 350 lbs. (159 Kg)

          2. Mycotic, ruptured or traumatic aneurysm

          3. Life expectancy &lt; 2 years

          4. MI, cerebral vascular accident or transient ischemic attack (TIA) within 6 months

          5. Expected occlusion or the need for re-implantation of significant mesenteric or renal
             arteries originating from the AAA

        Exclusion Criteria (Stent Graft Patients only)

          1. Aneurysm is symptomatic or tender

          2. Creatinine &gt; 2.5 mg/dl or patient on dialysis

          3. Thrombus in proximal and distal attachment area covering greater than 50% of the
             endoluminal surface
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>H. Wayne Hutman, MD</last_name>
    <role>Study Director</role>
    <affiliation>Cordis Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Newark Beth Israel Medical Center</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 5, 2005</study_first_submitted>
  <study_first_submitted_qc>October 5, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2005</study_first_posted>
  <last_update_submitted>April 30, 2009</last_update_submitted>
  <last_update_submitted_qc>April 30, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 1, 2009</last_update_posted>
  <responsible_party>
    <name_title>H. Wayne Hutman, MD / Director</name_title>
    <organization>Cordis</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

